WebDisclosure WebDisclosure
Basculer en Français
10205 Companies
210143 Keywords
140227 Articles
111398 Press releases
Headlines Articles Press releases SkylineDx Remove
  1. Home
  2. Companies
  3. SkylineDx
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/22/2025 at 17:40, 5 months 22 days ago

    SkylineDx's MERLIN_001 Trial Validates Melanoma Risk Test's Predictive Power

    Melanoma MERLIN_001 Trial Gene Expression Profiling Sentinel Node Metastasis SkylineDx
  • BRIEF

    published on 10/22/2025 at 17:40, 5 months 22 days ago

    L'essai MERLIN_001 de SkylineDx valide le pouvoir prédictif du test de risque de mélanome

    Mélanome SkylineDx Essai MERLIN_001 Profilage De L'expression Génétique Métastase Du Ganglion Sentinelle
  • PRESS RELEASE

    published on 10/22/2025 at 17:35, 5 months 22 days ago

    SkylineDx Publishes Landmark MERLIN_001 Trial in JAMA Surgery Validating the Predictive Power of the Merlin CP-GEP Test in Melanoma

    SkylineDx publishes results from the landmark MERLIN_001 trial in JAMA Surgery validating the predictive power of the Merlin CP-GEP Test for melanoma patients
    Melanoma MERLIN_001 Trial SkylineDx JAMA Surgery CP-GEP Test
    Logo of SkylineDx
Accesswire
  • Published on 04/13/2026 at 23:15, 9 hours 37 minutes ago

    Relevant Gold Completes Strategic Financing; Embarks on Largest Drilling Program in Company History

  • Published on 04/13/2026 at 23:00, 9 hours 52 minutes ago

    Sterling Metals Announces Sale Of Sail Pond Project

  • Published on 04/13/2026 at 22:25, 10 hours 27 minutes ago

    Findev Inc. Announces Dividend Updates Ex-Dividend Date

  • Published on 04/13/2026 at 16:00, 16 hours 52 minutes ago

    Norsemont To Participate in The Inaugural Swiss Mining Institute Conference in Panama City April 15-16

  • Published on 04/13/2026 at 15:15, 17 hours 37 minutes ago

    Findev Inc. Announces Dividend

View all ACCESSWIRE
EQS Group
  • Published on 04/14/2026 at 08:30, 22 minutes ago

    New HQ business centre at Science Park North43: ESPG launches first project with IWG in Cologne

  • Published on 04/14/2026 at 08:30, 22 minutes ago

    CMC Markets partners with Upvest to launch multi-currency securities in Germany

  • Published on 04/14/2026 at 08:29, 23 minutes ago

    Anemoi enters into amended and updated binding Sale and Purchase Agreement to acquire Trasna, Share Consolidation and Warrantholder Surrender and Subscription Offer

  • Published on 04/14/2026 at 08:05, 47 minutes ago

    Omio launches in ChatGPT, bringing its real-time multimodal travel search to 900 million users

  • Published on 04/14/2026 at 08:00, 52 minutes ago

    Fuller, Smith & Turner PLC: Appointment of Joint Corporate Broker

View all EQS
Les Echos
  • Published on 04/14/2026 at 08:30, 22 minutes ago

    ALPOU - Groupe POULAILLON - Projet offre publique d'achat obligatoire

  • Published on 04/13/2026 at 19:14, 13 hours 37 minutes ago

    ALTAREA - Déclaration d’opérations sur actions propres

  • Published on 04/13/2026 at 18:15, 14 hours 37 minutes ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2026

  • Published on 04/13/2026 at 18:15, 14 hours 37 minutes ago

    AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2026

  • Published on 04/13/2026 at 18:09, 14 hours 43 minutes ago

    Infotel : Cessation et mise en œuvre d’un nouveau contrat de liquidité avec Invest Securities.

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy